Literature DB >> 27403963

Methods for Acute and Subacute Murine Hindlimb Ischemia.

Michael E Padgett1, Timothy J McCord1, Joseph M McClung1, Christopher D Kontos2.   

Abstract

Peripheral artery disease (PAD) is a leading cause of cardiovascular morbidity and mortality in developed countries, and animal models that reliably reproduce the human disease are necessary to develop new therapies for this disease. The mouse hindlimb ischemia model has been widely used for this purpose, but the standard practice of inducing acute limb ischemia by ligation of the femoral artery can result in substantial tissue necrosis, compromising investigators' ability to study the vascular and skeletal muscle tissue responses to ischemia. An alternative approach to femoral artery ligation is the induction of gradual femoral artery occlusion through the use of ameroid constrictors. When placed around the femoral artery in the same or different locations as the sites of femoral artery ligation, these devices occlude the artery over 1 - 3 days, resulting in more gradual, subacute ischemia. This results in less substantial skeletal muscle tissue necrosis, which may more closely mimic the responses seen in human PAD. Because genetic background influences outcomes in both the acute and subacute ischemia models, consideration of the mouse strain being studied is important in choosing the best model. This paper describes the proper procedure and anatomical placement of ligatures or ameroid constrictors on the mouse femoral artery to induce subacute or acute hindlimb ischemia in the mouse.

Entities:  

Mesh:

Year:  2016        PMID: 27403963      PMCID: PMC4968086          DOI: 10.3791/54166

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  25 in total

1.  Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice.

Authors:  Joseph M McClung; Timothy J McCord; Sehoon Keum; Soraya Johnson; Brian H Annex; Douglas A Marchuk; Christopher D Kontos
Journal:  Am J Pathol       Date:  2012-03-21       Impact factor: 4.307

2.  An improved ameroid constrictor. Preliminary communication.

Authors:  J J Bredée
Journal:  J Surg Res       Date:  1969-02       Impact factor: 2.192

3.  Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.

Authors:  Kenneth Rosenfield; Michael R Jaff; Christopher J White; Krishna Rocha-Singh; Carlos Mena-Hurtado; D Christopher Metzger; Marianne Brodmann; Ernst Pilger; Thomas Zeller; Prakash Krishnan; Roger Gammon; Stefan Müller-Hülsbeck; Mark R Nehler; James F Benenati; Dierk Scheinert
Journal:  N Engl J Med       Date:  2015-06-24       Impact factor: 91.245

4.  The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia.

Authors:  Gale L Tang; David S Chang; Rajabrata Sarkar; Rong Wang; Louis M Messina
Journal:  J Vasc Surg       Date:  2005-02       Impact factor: 4.268

5.  Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery.

Authors:  Martin Schillinger; Schila Sabeti; Christian Loewe; Petra Dick; Jasmin Amighi; Wolfgang Mlekusch; Oliver Schlager; Manfred Cejna; Johannes Lammer; Erich Minar
Journal:  N Engl J Med       Date:  2006-05-04       Impact factor: 91.245

6.  Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure.

Authors:  Michael S Conte; Todd J Lorenz; Dennis F Bandyk; Alexander W Clowes; Gregory L Moneta; B Lynn Seely
Journal:  Vasc Endovascular Surg       Date:  2005 Jan-Feb       Impact factor: 1.089

7.  Subacute limb ischemia induces skeletal muscle injury in genetically susceptible mice independent of vascular density.

Authors:  Joseph M McClung; Timothy J McCord; Kevin Southerland; Cameron A Schmidt; Michael E Padgett; Terence E Ryan; Christopher D Kontos
Journal:  J Vasc Surg       Date:  2015-08-05       Impact factor: 4.268

Review 8.  12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.

Authors:  Konstantinos Marmagkiolis; Abdul Hakeem; Nishit Choksi; Malek Al-Hawwas; Mohan Mallikarjuna Rao Edupuganti; Massoud A Leesar; Mehmet Cilingiroglu
Journal:  Catheter Cardiovasc Interv       Date:  2014-05-08       Impact factor: 2.692

9.  Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.

Authors:  Gunnar Tepe; John Laird; Peter Schneider; Marianne Brodmann; Prakash Krishnan; Antonio Micari; Christopher Metzger; Dierk Scheinert; Thomas Zeller; David J Cohen; David B Snead; Beaux Alexander; Mario Landini; Michael R Jaff
Journal:  Circulation       Date:  2014-12-03       Impact factor: 29.690

10.  Murine model of hindlimb ischemia.

Authors:  Hiroshi Niiyama; Ngan F Huang; Mark D Rollins; John P Cooke
Journal:  J Vis Exp       Date:  2009-01-21       Impact factor: 1.355

View more
  8 in total

1.  Chemerin regulates normal angiogenesis and hypoxia-driven neovascularization.

Authors:  Cyrine Ben Dhaou; Kamel Mandi; Mickaël Frye; Angela Acheampong; Ayoub Radi; Benjamin De Becker; Mathieu Antoine; Nicolas Baeyens; Valérie Wittamer; Marc Parmentier
Journal:  Angiogenesis       Date:  2021-09-15       Impact factor: 10.658

2.  MicroRNAs in peripheral artery disease: potential biomarkers and pathophysiological mechanisms.

Authors:  Andrew Ring; Ahmed Ismaeel; Marissa Wechsler; Emma Fletcher; Evlampia Papoutsi; Dimitrios Miserlis; Panagiotis Koutakis
Journal:  Ther Adv Cardiovasc Dis       Date:  2022 Jan-Dec

3.  An optimized low-pressure tourniquet murine hind limb ischemia reperfusion model: Inducing acute ischemia reperfusion injury in C57BL/6 wild type mice.

Authors:  Marius Drysch; Christoph Wallner; Sonja Verena Schmidt; Felix Reinkemeier; Johannes Maximilian Wagner; Marcus Lehnhardt; Björn Behr
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

4.  Imaging the Proangiogenic Effects of Cardiovascular Drugs in a Diabetic Model of Limb Ischemia.

Authors:  J L Goggi; A Haslop; R Boominathan; K Chan; V Soh; P Cheng; E G Robins; K K Bhakoo
Journal:  Contrast Media Mol Imaging       Date:  2019-02-03       Impact factor: 3.161

5.  Deficiency of lncRNA SNHG12 impairs ischemic limb neovascularization by altering an endothelial cell cycle pathway.

Authors:  David A Gross; Henry S Cheng; Rulin Zhuang; Michael G McCoy; Daniel Pérez-Cremades; Zachary Salyers; A K M Khyrul Wara; Stefan Haemmig; Terence E Ryan; Mark W Feinberg
Journal:  JCI Insight       Date:  2022-01-11

6.  Dynamic Multiscale Regulation of Perfusion Recovery in Experimental Peripheral Arterial Disease: A Mechanistic Computational Model.

Authors:  Chen Zhao; Joshua L Heuslein; Yu Zhang; Brian H Annex; Aleksander S Popel
Journal:  JACC Basic Transl Sci       Date:  2022-01-05

7.  VEGF alleviates lower limb ischemia in diabetic mice by altering muscle fiber types.

Authors:  Lijing Jia; Peilin Zheng; Hongbo Wang; Lin Kang; Han Wu; Xiaobing Fu
Journal:  Exp Ther Med       Date:  2022-01-31       Impact factor: 2.447

8.  Regenerative Potential of the Product "CardioCell" Derived from the Wharton's Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia.

Authors:  Aleksandra Musiał-Wysocka; Marta Kot; Maciej Sułkowski; Marcin Majka
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.